Testing effectiveness (Phase 2)UnknownNCT04317248What this trial is testing"Cocktail" Therapy for Hepatitis B Related Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Yuehua Huang 600
Testing effectiveness (Phase 2)WithdrawnNCT05222438What this trial is testingTrial of Loncastuximab Tesirine in High Risk Diffuse Large B-cell Lymphoma Post TransplantWho this might be right forRelapsed Diffuse Large B-cell Lymphoma Barbara Ann Karmanos Cancer Institute
Not applicableNot Yet RecruitingNCT07476378What this trial is testingEvaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell MalignanciesWho this might be right forLymphoma, Large B-Cell, Diffuse (DLBCL)Lymphoma, FollicularLymphoma, Mantle-Cell+3 more Cancer Institute and Hospital, Chinese Academy of Medical Sciences 69
Not applicableLooking for participantsNCT07288515What this trial is testingObserv Prosp Study of Acalabrutinib in CLL Therapy in Real Clinical Practice in BelarusWho this might be right forChronic Lymphocytic Leukemia AstraZeneca 50
Early research (Phase 1)Looking for participantsNCT03595917What this trial is testingABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CMLWho this might be right forB-cell Acute Lymphoblastic LeukemiaChronic Myeloid Leukemia (CML) in Lymphoid Blast CrisisPhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia Ph+ ALL Marlise Luskin, MD 40
Large-scale testing (Phase 3)Study completedNCT00103285What this trial is testingCombination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic LeukemiaChildhood B Acute Lymphoblastic Leukemia Children's Oncology Group 5,377
Not applicableStudy completedNCT00890435What this trial is testingDecision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical TrialWho this might be right forBrain and Central Nervous System TumorsLeukemiaUnspecified Adult Solid Tumor, Protocol Specific+1 more Children's Oncology Group 53
Large-scale testing (Phase 3)UnknownNCT03650933What this trial is testingA Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma PatientsWho this might be right forDiffuse Large B-Cell Lymphoma, Unspecified Site Nanjing Yoko Biomedical Co., Ltd. 360
Testing effectiveness (Phase 2)WithdrawnNCT05966233What this trial is testingR-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell LymphomaWho this might be right forDiffuse Large B Cell Lymphoma RefractoryDiffuse Large B-cell Lymphoma Recurrent Fondazione Italiana Linfomi - ETS
Testing effectiveness (Phase 2)Study completedNCT00724984What this trial is testingStudy of the Safety and Tolerability of PCI-24781 in Patients With LymphomaWho this might be right forLymphomaHodgkin DiseaseLymphoma, Non-Hodgkin Pharmacyclics LLC. 55
Not applicableUnknownNCT03681938What this trial is testingIndication to Transplant Patients With High Risk B Cells Lymphoma in Metabolic Complete Remission?Who this might be right forLymphoma, B-Cell Institut Paoli-Calmettes 183
Not applicableStudy completedNCT00481858What this trial is testingKinetic Biomarker for Chronic Lymphocytic Leukemia PrognosisWho this might be right forChronic Lymphocytic Leukemia KineMed 150
Not applicableStudy completedNCT04695366What this trial is testingThe Potential of Patient-reported Outcome Measures in Detection of Relapse in Diffuse Large B-cell LymphomaWho this might be right forDiffuse Large B Cell LymphomaPatient Reported Outcome Herlev Hospital 250
Early research (Phase 1)Study completedNCT00003451What this trial is testingInterleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT03544281What this trial is testingTo Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)Who this might be right forMultiple Myeloma GlaxoSmithKline 153
Large-scale testing (Phase 3)UnknownNCT02772822What this trial is testingA Study Comparing the Efficiency and Safety of S-CHOP(Cyclophosphamide, Hydroxydaunomycin, Oncovin, and Prednisone) Versus R-CHOP in Untreated CD20(Cluster of Differentiation Antigen 20)-Positive DLBCL PatientsWho this might be right forDiffuse Large B Cell Lymphoma Sinocelltech Ltd. 330
Early research (Phase 1)Ended earlyNCT00963495What this trial is testingStudy Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological MalignancyWho this might be right forAcute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+4 more University Health Network, Toronto 11
Not applicableUnknownNCT05145101What this trial is testingPneumococcal Vaccination in Patients With Chronic Lymphocytic LeukaemiaWho this might be right forPneumococcal InfectionsChronic Lymphocytic LeukemiaVaccine-Preventable Diseases+1 more Hannah Garcia Garrido 150
Large-scale testing (Phase 3)Study completedNCT03570892What this trial is testingTisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin LymphomaWho this might be right forNon-Hodgkin Lymphoma Novartis Pharmaceuticals 330
Testing effectiveness (Phase 2)Active Not RecruitingNCT02586857What this trial is testingA Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)Who this might be right forGlioblastoma Multiforme Acerta Pharma BV 24